bioRxiv Science⌕ Search

Biology subjects

Kotnis, A.

Publications and source records attributed to Kotnis, A..

2 recordsLinked to original sources

Visualize, Explore, and Select: A protein Language Model-based Approach Enabling Navigation of Protein Sequence Space for Enzyme Discovery and Mining

The rapid expansion of protein sequence databases continues to outpace functional characterization, creating a persistent bottleneck in enzyme discovery and mining--particularly in large, heterogeneous, and sparsely annotated sequence spaces. This gap is amplified by visualization challenges and the lack of informed strategies for exploration, selection, and mining across sequence spaces. Here, we present an embedding-based workflow, implemented in a computational platform called SelectZyme, for alignment-free visualization and exploration of protein sequence space that combines protein language model (pLM) representations with dimensionality reduction and hierarchical density-based clustering. The approach links complementary visualizations of protein sequence space as low-dimensional landscapes, connectivity projections (minimum spanning trees), and dendrogram-based organization, enabling coherent interactive exploration and candidate selection across global context and local neighborhoods without relying on sequence-identity thresholds, EC numbers, conserved motifs, or predefined functional annotations. Across distinct case studies, we demonstrate that embedding-defined neighborhoods remain structurally conserved even when sequence identity falls within the twilight zone, and that coherent functional organization emerges also for modular protein segments in a fully unsupervised analysis. We also show how this workflow supports user friendly, interactive and scalable enzyme mining in a sparsely annotated, complex multi-family protein space surpassing > 100,000 sequences, enabling constrained candidate selection around experimentally validated anchors. By enabling interactive exploration across visualizations, supporting informed candidate selection, our workflow streamlines biocatalyst discovery and helps to bridge uncharacterized sequence-space to functional characterization campaigns - thus providing a broad starting point to downstream protein engineering, machine-learning-guided design cycles, and iterative experimental screening campaigns.

bioinformatics↗

Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide

BackgroundThe SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a positive-sense single-stranded RNA coronavirus responsible for the ongoing 2019-2020 COVID-19 outbreak. The highly contagious COVID-19 disease has spread to 216 countries in less than six months. Though several vaccine candidates are being claimed, an effective vaccine is yet to come. In present study we have designed and theoretically validated novel Multi-Patch Vaccines against SARS-CoV-2. MethodologyA novel reverse epitomics approach, "overlapping-epitope-clusters-to-patches" method is utilized to identify multiple antigenic regions from the SARS-CoV-2 proteome. These antigenic regions are here termed as "Ag-Patch or Ag-Patches", for Antigenic Patch or Patches. The identification of Ag-Patches is based on clusters of overlapping epitopes rising from a particular region of SARS-CoV-2 protein. Further, we have utilized the identified Ag-Patches to design Multi-Patch Vaccines (MPVs), proposing a novel methodology for vaccine design and development. The designed MPVs were analyzed for immunologically crucial parameters, physiochemical properties and cDNA constructs. ResultsWe identified 73 CTL (Cytotoxic T-Lymphocyte), 49 HTL (Helper T-Lymphocyte) novel Ag-Patches from the proteome of SARS-CoV-2. The identified Ag-Patches utilized to design MPVs cover 768 (518 CTL and 250 HTL) overlapping epitopes targeting different HLA alleles. Such large number of epitope coverage is not possible for multi-epitope vaccines. The large number of epitopes covered implies large number of HLA alleles targeted, and hence large ethnically distributed human population coverage. The MPVs:Toll-Like Receptor ectodomain complex shows stable nature with numerous hydrogen bond formation and acceptable root mean square deviation and fluctuation. Further, the cDNA analysis favors high expression of the MPVs constructs in human cell line. ConclusionHighly immunogenic novel Ag-Patches are identified from the entire proteome of SARS CoV-2 by a novel reverse epitomics approach. We conclude that the novel Multi-Patch Vaccines could be a highly potential novel approach to combat SARS-CoV-2, with greater effectiveness, high specificity and large human population coverage worldwide. O_FIG O_LINKSMALLFIG WIDTH=187 HEIGHT=200 SRC="FIGDIR/small/284992v1_ufig1.gif" ALT="Figure 1"> View larger version (84K): org.highwire.dtl.DTLVardef@176f27org.highwire.dtl.DTLVardef@82a4fcorg.highwire.dtl.DTLVardef@11db43forg.highwire.dtl.DTLVardef@12495b2_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOABSTRACT FIGURE:C_FLOATNO A Multi-Patch Vaccine design to combat SARS-CoV-2 and a method to prepare thereof. Multi-Patch Vaccine designing to combat SARS-CoV-2 infection by reverse epitomics approach, "Overlapping-epitope-clusters-to-patches" method. C_FIG

immunology↗